AI platform that discovers and validates drug combination therapies by modeling multiple interacting biological layers simultaneously.
Olio Labs' Combination Design Engine uses AI trained on real human drug-response data curated with custom HITL tools to identify ranked multi-drug therapies. The platform models multiple biological layers to balance desired responses against side effects and ranks combinations by expected benefit and side-effect burden. Top candidates are validated in a high-throughput in vivo rodent phenomics platform that predicts human efficacy, safety, and tolerability from 24-hour experiments. Current focus is on obesity therapeutics. Olio Labs is a product of Olio Labs.